Benzinga | Nov 18, 2020 06:26AM EST

HC Wainwright & Co. Downgrades Summit Therapeutics to Neutral

HC Wainwright & Co. downgrades Summit Therapeutics (NASDAQ:SMMT) from Buy to Neutral.